Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasilios Athyros

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Expert Review of Cardiovascular Therapy|December 21, 2021
Serum uric acid: a mediator of cardio-reno-metabolic diseasesNiki Katsiki, Vasilios Athyros
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2015
Screening for Primary Aldosteronism: Whom and How?Michael Doumas, Vasilios Athyros, Vasilios Papademetriou
Cardiology|May 14, 2015
Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?Michael Doumas, Vasilios Athyros, Asterios Karagiannis
Hormones (Athens, Greece)|October 29, 2018
Metabolic syndrome: joint diagnostic criteria and links with comorbiditiesNiki Katsiki, Michael Doumas, Vasilios Athyros
Journal of Clinical Hypertension (Greenwich, Conn.)|December 15, 2015
Fitness: The "Secret" of Vascular YouthMichael Doumas, Chrysoula Boutari, Vasilios Athyros, et al.
Angiology|July 12, 2015
Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to GoMichael Doumas, Vasilios Papademetriou, Vasilios Athyros, et al.
Current Vascular Pharmacology|January 22, 2019
Effects of Lipid Lowering Drugs on Arterial Stiffness: One More Way to Reduce Cardiovascular Risk?Andromachi Reklou, Niki Katsiki, Asterios Karagiannis, et al.
Current Drug Targets|November 14, 2014
PDE-5 inhibitors: clinical pointsMichael Doumas, Antonios Lazaridis, Niki Katsiki, et al.
Current Clinical Pharmacology|August 8, 2018
SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the LiteratureDimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, et al.
Current Vascular Pharmacology|February 5, 2020
Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical PracticeDimitrios Patoulias, Konstantinos Stavropoulos, Konstantinos Imprialos, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Expert Review of Cardiovascular Therapy|December 21, 2021
Serum uric acid: a mediator of cardio-reno-metabolic diseasesNiki Katsiki, Vasilios Athyros
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2015
Screening for Primary Aldosteronism: Whom and How?Michael Doumas, Vasilios Athyros, Vasilios Papademetriou
Cardiology|May 14, 2015
Transcatheter Renal Sympathetic Denervation: Chasing a Chimera or a Matter of Technological Improvements?Michael Doumas, Vasilios Athyros, Asterios Karagiannis
Hormones (Athens, Greece)|October 29, 2018
Metabolic syndrome: joint diagnostic criteria and links with comorbiditiesNiki Katsiki, Michael Doumas, Vasilios Athyros
Journal of Clinical Hypertension (Greenwich, Conn.)|December 15, 2015
Fitness: The "Secret" of Vascular YouthMichael Doumas, Chrysoula Boutari, Vasilios Athyros, et al.
Angiology|July 12, 2015
Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to GoMichael Doumas, Vasilios Papademetriou, Vasilios Athyros, et al.
Current Vascular Pharmacology|January 22, 2019
Effects of Lipid Lowering Drugs on Arterial Stiffness: One More Way to Reduce Cardiovascular Risk?Andromachi Reklou, Niki Katsiki, Asterios Karagiannis, et al.
Current Drug Targets|November 14, 2014
PDE-5 inhibitors: clinical pointsMichael Doumas, Antonios Lazaridis, Niki Katsiki, et al.
Current Clinical Pharmacology|August 8, 2018
SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the LiteratureDimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, et al.
Current Vascular Pharmacology|February 5, 2020
Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical PracticeDimitrios Patoulias, Konstantinos Stavropoulos, Konstantinos Imprialos, et al.
Pageof 3